Archive · 3 Sep 2025
New Drug Baxdrostat Shows Promise in Treating Resistant Hypertension
Imagine your blood pressure is too high, even with medicine.
Some people have this problem, called resistant hypertension.
A new drug, baxdrostat, is being tested.
It helps lower blood pressure better than other medicines by stopping a hormone called aldosterone, which makes your body hold too much salt and water.
In a study, it lowered blood pressure significantly, with some patients reaching healthy levels.
This new drug could help prevent heart attacks, strokes, and kidney problems.
It's like a new tool to help people with high blood pressure.
Baxdrostat drug trials show significant blood pressure reduction in patients with resistant hypertension.
The study included 796 patients from 214 clinics globally.
Patients taking baxdrostat experienced a 9-10 mmHg greater reduction in blood pressure than those on a placebo.
About four in ten patients taking the drug reached normal blood pressure.
The findings were presented at the European Society of Cardiology congress.
- Who
- Patients with resistant hypertension
- What
- Baxdrostat drug trial results
- When
- Presented at the European Society of Cardiology congress
- Where
- 214 clinics worldwide
- Why
- To provide a new treatment option for resistant hypertension
- Drug Name
- Baxdrostat
- Study Location
- 214 clinics worldwide
- Participants
- 796 patients
- Blood Pressure Reduction
- 9-10 mmHg more than placebo
- Achieved Normal BP
- 4 in 10 patients
- Presented at
- European Society of Cardiology congress